{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-108145","form_type":"8-K","ticker":"ELOX","cik":"0001035354","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2021-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.923675+00:00","generated_at":"2026-06-29T08:33:42.443190+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Eloxx Pharmaceuticals appoints Daniel Geffken as Principal Accounting Officer","bullets":["Daniel Geffken, Interim CFO since April 1, 2021, added role of Principal Accounting Officer on August 17, 2021.","Geffken provides services through Danforth Advisors, LLC.","No departure or change in CFO role; Geffken remains Principal Financial Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-108145","json":"https://secwatch.observer/filing/0001104659-21-108145.json","markdown":"https://secwatch.observer/filing/0001104659-21-108145.md","text":"https://secwatch.observer/filing/0001104659-21-108145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000110465921108145/0001104659-21-108145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000110465921108145/tm2125622d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T08:33:42.443190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08c7ac457a","claim":"Daniel Geffken was appointed as Principal Accounting Officer at Eloxx Pharmaceuticals, Inc..","evidence_excerpt":"On August 17, 2021, the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed the Company’s Interim Chief Financial Officer, Daniel Geffken, to serve as the Company’s Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465921108145/0001104659-21-108145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}